#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Charles Baum Email
CEO and President . Mirati Therapeutics
How to contact Charles Baum
Join and see Charles's contact info for free!Current Roles
Employees:
563Revenue:
$73.5MAbout
Mirati Therapeutics develops molecularly targeted, single agent and immuno-oncology combination therapies intended to treat cancer. Mirati's approach combines the three most important factors in oncology drug development, 1) researching and developing drug candidates that target genetic and epigenetic drivers of cancer, 2) designing creative and agile clinical development strategies that select for patients whose tumors are dependent on specific driver alterations, and 3) leveraging a highly accomplished oncology precision medicine leadership team. The Mirati team uses a blueprint - proven by their prior work - for developing potential breakthrough cancer therapies, with accelerated development paths, in order to improve outcomes for patients. Mirati is advancing three drug candidates through clinical development for multiple oncology indications.Mirati Therapeutics Address
3545 Cray CourtSan Diego, CA
United States